Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹426.95
3.50 (0.83%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹16.33K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
82.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹266.7+60.1%
52W High₹1,121.15-61.9%
Current Price
₹426.95
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹341.56
Upper Circuit₹512.34
Reference Price
₹426.95
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹331.6
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹340.85
10/20 Bullish Cross detected 1 day(s) ago
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
46%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
428.92
EMA50
413.59
EMA200
563.43
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows4
Lower Highs4
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹448.00
₹505.00
₹518.12
₹545.00
₹856.45
Support (Below)
₹418.55
₹406.50
₹399.45
₹391.05
₹355.05
Volume Analysis
TrendDECREASING
Change-62.10%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bullish Cross
1 day ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹422.68
3% Risk₹414.14
5% Risk₹405.60
7% Risk (Custom)
₹397.06Technical Levels
1x ATR (Volatility)₹408.83
2x ATR (Swing)₹390.71
3x ATR (Trend)₹372.59
Immediate Support₹418.55
Moving Averages
EMA 50 (Trend)₹413.59
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹376.7 Cr | ₹549.3 Cr | ₹555.6 Cr | ₹544.6 Cr |
| Net Profit | ₹42 Cr | ₹48.8 Cr | ₹74.1 Cr | ₹36.7 Cr |
| EPS | — | ₹1.28 | ₹1.94 | ₹0.96 |
| Operating Profit | ₹83.3 Cr | ₹118.1 Cr | ₹136.6 Cr | ₹96.7 Cr |
ROE
15.79%
ROCE
17.99%
Debt/Equity
0.16
Current Ratio
2.43
OPM
17.75%
NPM
6.74%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 06 Aug 2024 | Annual General Meeting | AGM |
| 12 Dec 2023 | Annual General Meeting | AGM |
| 09 Sept 2022 | Interim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share | SPECIAL_DIVIDEND |
| 11 Aug 2022 | Annual General Meeting | AGM |
| 13 May 2022 | Interim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share | SPECIAL_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for COHANCE
View All
positive
Google News - India Markets 30d ago
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
COHANCEKALPATARUHealthcareRealty
positive
Google News - India Markets 30d ago
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
COHANCEKALPATARUHealthcareRealty
NEWS
negative
Business Standard - Markets 31d ago
NIIT Learning Systems Ltd leads losers in 'A' group
Sky Gold & Diamonds Ltd, Torrent Power Ltd, Cohance Lifesciences Ltd and Kirloskar Brothers Ltd are among the other losers in the BSE's 'A' group today, 13 May 2026.
BSECOHANCEGROWWPOWERGVPILKIRLOSBROSKIRLOSINDNIITLTDNIITMTSRSYSTEMSSKYGOLDSMARTENTDPOWERSYSTORNTPOWERUTLSOLARCapital GoodsConsumer Durables